The introduction of nicotinamide being a nicotine alternative in e-cigarette and smokeless items represents a big regulatory problem for your FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is known to work as a sedative at large dosages6. The promises created by Nicotine Riv